Literature DB >> 19883518

Anticancer activities of artemisinin and its bioactive derivatives.

Gary L Firestone1, Shyam N Sundar.   

Abstract

Artemisinin, a sesquiterpene lactone derived from the sweet wormwood plant Artemisia annua, and its bioactive derivatives exhibit potent anticancer effects in a variety of human cancer cell model systems. The pleiotropic response in cancer cells includes growth inhibition by cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration, and modulation of nuclear receptor responsiveness. These effects of artemisinin and its derivatives result from perturbations of many cellular signalling pathways. This review provides a comprehensive discussion of these cellular responses, and considers the ramifications for the potential development of artemisinin-based compounds in anticancer therapeutic and preventative strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883518     DOI: 10.1017/S1462399409001239

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  44 in total

1.  Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation.

Authors:  Sujayita Roy; Ran He; Arun Kapoor; Michael Forman; Jennifer R Mazzone; Gary H Posner; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a Semi-Synthetic Derivative of Artemisinin: A Caspase-Related Mechanism.

Authors:  Leila Jamalzadeh; Hossein Ghafoori; Mahmoodreza Aghamaali; Reyhaneh Sariri
Journal:  Iran J Biotechnol       Date:  2017-09-27       Impact factor: 1.671

3.  Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.

Authors:  Kris G Hargraves; Lin He; Gary L Firestone
Journal:  Mol Carcinog       Date:  2015-03-19       Impact factor: 4.784

4.  Synergic effects of artemisinin and resveratrol in cancer cells.

Authors:  Peichun Li; Sen Yang; Mengmeng Dou; Youran Chen; Jie Zhang; Xiaoyan Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-22       Impact factor: 4.553

5.  Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.

Authors:  Lin Ye; Yongning Jia; K E Ji; Andrew J Sanders; Kan Xue; Jiafu Ji; Malcolm D Mason; Wen G Jiang
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

6.  The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells.

Authors:  Rui Cheng; Cen Li; Chaoyang Li; Ling Wei; Lei Li; Yang Zhang; Yachao Yao; Xiaoqiong Gu; Weibin Cai; Zhonghan Yang; Jianxing Ma; Xia Yang; Guoquan Gao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-15       Impact factor: 4.799

7.  Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.

Authors:  Ravit Arav-Boger; Ran He; Chuang-Jiun Chiou; Jianyong Liu; Lauren Woodard; Andrew Rosenthal; Lorraine Jones-Brando; Michael Forman; Gary Posner
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

8.  Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.

Authors:  Kalvin Q Tran; Antony S Tin; Gary L Firestone
Journal:  Anticancer Drugs       Date:  2014-03       Impact factor: 2.248

9.  Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish.

Authors:  Qian Ba; Juan Duan; Jia-qiang Tian; Zi-liang Wang; Tao Chen; Xiao-guang Li; Pei-zhan Chen; Song-jie Wu; Li Xiang; Jing-quan Li; Rui-ai Chu; Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2013-05-27       Impact factor: 6.150

10.  Antimalarial activities of medicinal plants and herbal formulations used in Thai traditional medicine.

Authors:  Artitaya Thiengsusuk; Wanna Chaijaroenkul; Kesara Na-Bangchang
Journal:  Parasitol Res       Date:  2013-01-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.